scholarly journals Rodent Models to Analyze the Glioma Microenvironment

ASN NEURO ◽  
2021 ◽  
Vol 13 ◽  
pp. 175909142110050
Author(s):  
Susann Hetze ◽  
Ulrich Sure ◽  
Manfred Schedlowski ◽  
Martin Hadamitzky ◽  
Lennart Barthel

Animal models are still indispensable for understanding the basic principles of glioma development and invasion. Preclinical approaches aim to analyze the treatment efficacy of new drugs before translation into clinical trials is possible. Various animal disease models are available, but not every approach is useful for addressing specific questions. In recent years, it has become increasingly evident that the tumor microenvironment plays a key role in the nature of glioma. In addition to providing an overview, this review evaluates available rodent models in terms of usability for research on the glioma microenvironment.

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Tian Zhou ◽  
Zenan Yuan ◽  
Jianyu Weng ◽  
Duanqing Pei ◽  
Xin Du ◽  
...  

AbstractMesenchymal stromal cells (MSCs), also known as mesenchymal stem cells, have been intensely investigated for clinical applications within the last decades. However, the majority of registered clinical trials applying MSC therapy for diverse human diseases have fallen short of expectations, despite the encouraging pre-clinical outcomes in varied animal disease models. This can be attributable to inconsistent criteria for MSCs identity across studies and their inherited heterogeneity. Nowadays, with the emergence of advanced biological techniques and substantial improvements in bio-engineered materials, strategies have been developed to overcome clinical challenges in MSC application. Here in this review, we will discuss the major challenges of MSC therapies in clinical application, the factors impacting the diversity of MSCs, the potential approaches that modify MSC products with the highest therapeutic potential, and finally the usage of MSCs for COVID-19 pandemic disease.


2009 ◽  
Vol 390 (2) ◽  
pp. 175-179 ◽  
Author(s):  
Dejan Caglič ◽  
Gregor Kosec ◽  
Lea Bojič ◽  
Thomas Reinheckel ◽  
Vito Turk ◽  
...  

Abstract Validation of drug targets and subsequent preclinical studies are usually carried out on animal disease models, with mouse being the most commonly used. However, results from mouse models cannot always be directly related to human disease. Major discrepancies between the properties of murine and human variants were observed during the evaluation of compounds targeting cathepsins S and K. It is important, therefore, to know whether similar differences exist between murine and human cathepsin B. Thus, both enzymes were expressed and biochemically characterized. The enzymes exhibited similar biochemical properties, indicating that cathepsin B transgenic mouse models could be useful for studying its role in human pathologies.


Stem Cells ◽  
2016 ◽  
Vol 34 (7) ◽  
pp. 1709-1729 ◽  
Author(s):  
Andrew M. Hoffman ◽  
Steven W. Dow

Author(s):  
Tomas Hökfelt ◽  
Margarita Diez ◽  
Tiejun Shi ◽  
Jari Koistinaho ◽  
Dora Games ◽  
...  

2012 ◽  
Vol 20 (8) ◽  
pp. 854-862 ◽  
Author(s):  
Y. Lai ◽  
X.-P. Yu ◽  
Y. Zhang ◽  
Q. Tian ◽  
H. Song ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document